Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_3
1
33%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(2)
Other(1)

Detailed Status

unknown1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
withdrawn133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_3

Treatment Chronic UTI Post Kidney Transplant

NCT05967130
unknownnot_applicable

Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety

NCT05973721
withdrawnphase_1

Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes

NCT04289948

Clinical Trials (3)

Showing 3 of 3 trials
NCT05967130Phase 3

Treatment Chronic UTI Post Kidney Transplant

Terminated
NCT05973721Not Applicable

Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety

Unknown
NCT04289948Phase 1

Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3